UK Markets close in 3 hrs 49 mins

Fresenius Medical Care AG & Co. KGaA (FME.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
58.06-1.62 (-2.71%)
As of 05:35PM CET. Market open.
Full screen
Previous close59.68
Open59.30
Bid0.00 x 38700
Ask0.00 x 105300
Day's range57.60 - 59.44
52-week range52.06 - 71.14
Volume628,022
Avg. volume659,446
Market cap17.011B
Beta (5Y monthly)1.01
PE ratio (TTM)18.53
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.34 (2.35%)
Ex-dividend date21 May 2021
1y target estN/A
All
News
  • Business Wire

    Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality Improvement Award

    HONG KONG, December 22, 2021--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, was presented with the prestigious Australian Council for Healthcare Standards (ACHS) Global Quality Improvement Award at a virtual ceremony held on Thursday 25 November. The award was given for the organization’s successful implementation of an electronic auditing program across 290 of its dialysis clinics in 10 markets across Asia Pacific. Called ‘WeA

  • Business Wire

    Fresenius Medical Care launches new mobile app to empower and engage nurses

    HONG KONG, December 21, 2021--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced the launch of Carrie, a custom-built mobile app that connects, informs and supports Fresenius Kidney Care nurses and clinical teams in the Asia Pacific region. As one of the largest employers of nurses across a vast network of dialysis clinics, the organization was motivated to develop a digital platform that champions nurses at the hear

  • EQS Group

    Fresenius Medical Care AG & Co. KGaA announces changes to Management Board, reflecting the transformation to the company's new operating model

    DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Personnel01.12.2021 / 08:30 The issuer is solely responsible for the content of this announcement.Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced changes to the Management Board effective on January 1, 2022. They follow a unanimous decision by the Supervisory Board of Fresenius Medical Care Management AG to adapt the composition of the Management Board